| Name | sodium,(2R)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate |
|---|---|
| Synonyms |
Sodium (2R)-2-[6-(4-chlorophenoxy)hexyl]-2-oxiranecarboxylate
2-Oxiranecarboxylic acid, 2-[6-(4-chlorophenoxy)hexyl]-, sodium salt, (2R)- (1:1) cc-140 (+)-Etomoxir (sodium salt) ANTI-EAPII(TTRAP) (2R)-2-[6-(4-Chlorophenoxy)hexyl]oxiranecarboxylic acid sodium salt MFCD07787411 (+)-Etomoxir sodium salt (R)-(+)-Etomoxir (sodium salt) |
| Description | (R)-Etomoxir sodium salt is the R-form of Etomoxir sodium salt, acts as an inhibitorof carnitine palmitoyltransferase I (CPT-I), and inhibits palmitate β-oxidation in human, rat and guinea pig. |
|---|---|
| Related Catalog | |
| Target |
CPT-1[1] |
| In Vitro | (R)-Etomoxir sodium salt is the R-form of Etomoxir sodium salt, acts as an inhibitorof carnitine palmitoyltransferase I (CPT-I), and inhibits palmitate β-oxidation in human, rat and guinea pig[1]. |
| References |
| Molecular Formula | C15H18ClNaO4 |
|---|---|
| Molecular Weight | 320.744 |
| Exact Mass | 320.079132 |
| PSA | 61.89000 |
| LogP | 2.18820 |
| Storage condition | -20℃ |
| Hazard Codes | Xn: Harmful; |
|---|---|
| Risk Phrases | 22 |
| RIDADR | UN 2811 6.1/PG 3 |